-
1دورية أكاديمية
المؤلفون: Liisi Raam, Ilona Hartmane, Skaidra Valiukevičienė, Arfenya E. Karamova, Eniko Telegdy, Ivan Botev, Diana Marina, Simone Rubant, Teotonio Albuquerque, Maria Magdalena Constantin
المصدر: Frontiers in Immunology, Vol 15 (2024)
مصطلحات موضوعية: real-world, severity of illness index, patient-reported outcomes, psoriasis, systemic therapy, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Bruce Strober, April Armstrong, Simone Rubant, Manish Patel, Tianshuang Wu, Huzefa Photowala, Jeffrey Crowley
المصدر: Journal of Dermatological Treatment, Vol 33, Iss 7, Pp 2991-2996 (2022)
مصطلحات موضوعية: psoriasis, incomplete responder, switching treatments, risankizumab, Dermatology, RL1-803
وصف الملف: electronic resource
-
3
المؤلفون: Jeffrey J. Crowley, Richard G. Langley, Kenneth B. Gordon, Andreas Pinter, Laura K. Ferris, Simone Rubant, Huzefa Photowala, Zhenyi Xue, Tianshuang Wu, Tianyu Zhan, Stefan Beeck, Megha Shah, Richard B. Warren
المصدر: Dermatology and therapy. 12(2)
مصطلحات موضوعية: Dermatology
-
4
المؤلفون: David A. Williams, Kilian Eyerich, Ahmed M. Soliman, P Weisenseel, Diamant Thaçi, Andreas Pinter, Simone Rubant, M Sebastian, K. Unnebrink
المصدر: Journal of the European Academy of Dermatology and Venereology : JEADVReferences. 35(8)
مصطلحات موضوعية: Adult, medicine.medical_specialty, Visual analogue scale, Dermatology, Hospital Anxiety and Depression Scale, Severity of Illness Index, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Double-Blind Method, Fumarates, Internal medicine, Psoriasis, Germany, 050602 political science & public administration, medicine, Humans, Patient Reported Outcome Measures, Risankizumab, business.industry, 05 social sciences, Antibodies, Monoclonal, Dermatology Life Quality Index, medicine.disease, 0506 political science, Infectious Diseases, Treatment Outcome, Quality of Life, Itching, Anxiety, medicine.symptom, business
-
5
المؤلفون: Craig L. Leonardi, Jiewei Zeng, Mark Lebwohl, Lluís Puig, Gabriela Alperovich, Simone Rubant, Ranjeeta Sinvhal, Kim A. Papp, Yiwei Zhao
المصدر: Journal of the American Academy of Dermatology. 85:AB86
مصطلحات موضوعية: medicine.medical_specialty, Risankizumab, business.industry, Physical therapy, medicine, Dermatology, Extension (predicate logic), Open label, business, Interim analysis
-
6
المؤلفون: Hongwei Wang, Simone Rubant, Julia-Tatjana Maul, Charles Lynde, Andrea Szegedi, Mamitaro Ohtsuki, Diamant Thaçi, Kim A. Papp, Ahmed M. Soliman
المصدر: Journal of the American Academy of Dermatology. 85:AB71
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Multinational corporation, Psoriasis, Internal medicine, Baseline characteristics, medicine, Observational study, Dermatology, medicine.disease, business, Value (mathematics)
-
7
المؤلفون: Simone Rubant, Jiewei Zeng, Mark Lebwohl, Craig L. Leonardi, Joaquin Mario Valdes, Kim A. Papp
المصدر: Journal of the American Academy of Dermatology. 83:AB17
مصطلحات موضوعية: medicine.medical_specialty, Risankizumab, Physical medicine and rehabilitation, business.industry, Medicine, Dermatology, Extension (predicate logic), Open label, business, Term (time)
-
8
المؤلفون: Jashin J. Wu, Simone Rubant, Kim A. Papp, Diamant Thaçi, Henrique D. Teixeira, David A. Williams, Mareike Bereswill, Alan Menter
المصدر: Journal of the American Academy of Dermatology. 73:410-419.e6
مصطلحات موضوعية: Adult, Male, Canada, medicine.medical_specialty, Time Factors, Tuberculosis, Injections, Subcutaneous, serious infections, Population, Postmarketing surveillance, Dermatology, registry, Risk Assessment, Severity of Illness Index, Drug Administration Schedule, Internal medicine, Product Surveillance, Postmarketing, medicine, Adalimumab, Humans, Psoriasis, Registries, Myocardial infarction, Medical prescription, Adverse effect, education, Aged, Retrospective Studies, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, adverse events, United States, Surgery, Survival Rate, Treatment Outcome, Female, Observational study, Patient Safety, business, long-term safety, malignancy, Follow-Up Studies, medicine.drug